Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial.

Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial.

Ticagrelor vs Clopidogrel in high bleeding risk patients with ACS

Improving Lipid Management for Patients Post-ACS

Improving Lipid Management for Patients Post-ACS

Improving Lipid Management for Patients Post-ACS

Improving Lipid Management for Patients Post-ACS

Improving Lipid Management for Patients Post-ACS

Watch Prof. Pasquale Perrone-Filardi from Department of Clinical Medicine, Cardiovascular and Immunology Sciences, Federico II University, Naples sharing insights on improving lipid management for patients post-ACS.

The role of the patient in Achieving LDL-C Target

The role of the patient in Achieving LDL-C Target

Identifying and treating patients with high Lipidaemia risk post-ACS

Watch Prof. Pasquale Perrone-Filardi from Department of Clinical Medicine, Cardiovascular and Immunology Sciences, Federico II University, Naples sharing insights on Identifying and treating patients with high lipidaemia risk post-ACS.

Identifying and treating patients with high Lipidaemia risk post-ACS